Literature DB >> 16155047

Epirubicin for breast cancer may cause considerable venous sclerosis.

Paula Bolton-Maggs1, Aileen Flavin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16155047      PMCID： PMC1246081          DOI： 10.1136/bmj.38574.659225.79

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

Review 1.  Extravasation: a dreaded complication of chemotherapy.

Authors:  D L Schrijvers
Journal:  Ann Oncol       Date:  2003       Impact factor: 32.976

Review 2.  Prevention and management of extravasation of cytotoxic drugs.

Authors:  G Bertelli
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606
  2 in total
  3 in total

1.  Epirubicin seems to cause venous sclerosis.

Authors:  Elaine Lennan; Janice M Middleton; Julia Luken
Journal:  BMJ       Date:  2005-10-22

2.  Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer-a survey of oncology nurses and physicians.

Authors:  N LeVasseur; C Stober; K Daigle; A Robinson; S McDiarmid; S Mazzarello; B Hutton; A Joy; D Fergusson; J Hilton; M McInnes; M Clemons
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

3.  The Development and Testing of a Chemotherapy-Induced Phlebitis Severity (CIPS) Scale for Patients Receiving Anthracycline Chemotherapy for Breast Cancer.

Authors:  Valerie Harris; Meinir Hughes; Rosie Roberts; Gina Dolan; E Mark Williams
Journal:  J Clin Med       Date:  2020-03-05       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.